| For: | Ríos-Ríos WJ, Sosa-Luis SA, Torres-Aguilar H. Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes. World J Diabetes 2021; 12(5): 603-615 [PMID: 33995848 DOI: 10.4239/wjd.v12.i5.603] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i5/603.htm |
| Number | Citing Articles |
| 1 |
Irina Buckle, Josephine M. Forbes. Type 1 Diabetes in 2023 - From Real Practice to Open Questions. 2023; doi: 10.5772/intechopen.108528
|
| 2 |
Aiswarya Venkata Suresh Kumar, Julia Babensee. Biomaterial‐Focused Strategies Targeting Dendritic Cells for Autoimmune Disease Treatment. Journal of Biomedical Materials Research Part A 2026; 114(7) doi: 10.1002/jbm.a.70107
|
| 3 |
Nélio A.J. Oliveira, Handan Sevim. Dendritic Cell Differentiation from Human Induced Pluripotent Stem Cells: Challenges and Progress. Stem Cells and Development 2022; 31(9-10) doi: 10.1089/scd.2021.0305
|
| 4 |
Bahar Naseri, Shiva Alipour, Javad Masoumi, Amirhossein Hatami‐Sadr, Edris Vaysi, Nima Hemmat, Nazila Alizadeh, Behzad Baradaran. RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-024-09572-8
|
| 5 |
Vasily Kurilin, Marina Fisher, Irina Obleukhova, Sergey Sennikov. Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances. International Journal of Molecular Sciences 2026; 27(2) doi: 10.3390/ijms27020585
|
| 6 |
Fangfang Jin, Weidong Wu, Xuan Yang, Xiang Fan, Xiaosen Zhao, Wei Liu, Xinrong Fan. Dendritic Cells as Immunometabolic Regulatory Nodes in Diabetes: Molecular Mechanisms and Therapeutic Reprogramming. International Journal of Molecular Sciences 2026; 27(13) doi: 10.3390/ijms27136057
|
| 7 |
Kamile Akça, Derya Butakın Ayhan, Aynur Aytekin Özdemir. Chronic burden or silent companion? Experiences of children with type 1 diabetes: A metaphor and sentiment analysis. Journal of Pediatric Nursing 2025; 85 doi: 10.1016/j.pedn.2025.07.033
|
| 8 |
Le Dai, Qing Wang. Two‐pronged approach: Therapeutic effect of biological scaffold combined with immune intervention and β‐cell replacement on type 1 diabetic mice. Diabetes, Obesity and Metabolism 2025; 27(6) doi: 10.1111/dom.16373
|
| 9 |
Nokwanda N. Ngcobo, Ntethelelo H. Sibiya. Type 1 Diabetes Mellitus Pathogenesis: Mechanisms, Early Diagnostic Strategies, and Emerging Therapeutic Approaches. Pathophysiology 2026; 33(3) doi: 10.3390/pathophysiology33030048
|
| 10 |
Caitlin N. Suire, Mangesh D. Hade. Extracellular Vesicles in Type 1 Diabetes: A Versatile Tool. Bioengineering 2022; 9(3) doi: 10.3390/bioengineering9030105
|
| 11 |
Melanie Rodacki, Karina Ribeiro Silva, Debora Batista Araujo, Joana R. Dantas, Maria Eduarda Nascimento Ramos, Lenita Zajdenverg, Leandra Santos Baptista. Immunomodulatory agents and cell therapy for patients with type 1 diabetes. Archives of Endocrinology and Metabolism 2024; 68 doi: 10.20945/2359-4292-2024-0233
|
| 12 |
Shiva Alipour, Tohid Kazemi, Mohammad Reza Sadeghi, Javad Ahmadian Heris, Javad Masoumi, Bahar Naseri, Elham Baghbani, Sepideh Sohrabi, Behzad Baradaran. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro. International Immunopharmacology 2024; 126 doi: 10.1016/j.intimp.2023.111230
|
| 13 |
Liu YANG, Xuejiao ZHANG, Qing LIU, Yan WEN, Qing WANG. Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes. Minerva Endocrinology 2023; 48(4) doi: 10.23736/S2724-6507.22.03723-X
|
| 14 |
Khalid Siddiqui, Shaik Sarfaraz Nawaz. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. ImmunoTargets and Therapy 2023; doi: 10.2147/ITT.S417917
|
| 15 |
Fangfang Jin, Lingxiang Xie, Hongqi Zhang, Xiang Fan, Jiaxing Tian, Wei Liu, Yang Xiao, Xinrong Fan. Dendritic Cells: Origin, Classification, Development, Biological Functions, and Therapeutic Potential. MedComm 2025; 6(11) doi: 10.1002/mco2.70455
|
| 16 |
Nick Giannoukakis. Tolerogenic dendritic cells in type 1 diabetes: no longer a concept. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1212641
|
| 17 |
Honorio Torres-Aguilar, Sorely Adelina Sosa-Luis, Alexia Almaraz-Arreortua, William de Jesús Ríos-Ríos. Harnessing monocyte-derived dendritic cells for evaluating T cell response by mixed leukocyte reaction. Exploration of Immunology 2025; 5 doi: 10.37349/ei.2025.1003201
|
| 18 |
William de Jesús Ríos-Ríos, Honorio Torres-Aguilar. Graft-Versus-Host Disease. Methods in Molecular Biology 2025; 2907 doi: 10.1007/978-1-0716-4430-0_13
|
| 19 |
Mahmoud Singer, Fouad Kandeel, Mohamed I. Husseiny. Salmonella-Based Vaccine: A Promising Strategy for Type 1 Diabetes. Vaccines 2025; 13(4) doi: 10.3390/vaccines13040405
|